Your browser doesn't support javascript.
loading
A Case of COVID-19-Induced Lymphocytosis in a Patient With Treatment-Naive CLL: Should It Be treated?
Safarpour, Damoun; Srinivasan, Krishnan; Farooqui, Marwah; Roth, Connor; Ghouse, Masood.
Afiliação
  • Safarpour D; Department of Internal Medicine-Hematology and Oncology, Midwestern University and Franciscan Health, Olympia Fields, IL. Electronic address: damoun.safarpour@franciscanalliance.org.
  • Srinivasan K; Department of Internal Medicine-Hematology and Oncology, Midwestern University and Franciscan Health, Olympia Fields, IL.
  • Farooqui M; Department of Internal Medicine-Hematology and Oncology, Midwestern University and Franciscan Health, Olympia Fields, IL.
  • Roth C; Department of Internal Medicine- Hematology and Oncology, Franciscan Health, Olympia Fields, IL.
  • Ghouse M; Department of Internal Medicine-Hematology and Oncology, Midwestern University and Franciscan Health, Olympia Fields, IL.
Clin Lymphoma Myeloma Leuk ; 21(1): 69-72, 2021 01.
Article em En | MEDLINE | ID: mdl-33039356

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / COVID-19 / Linfocitose Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / COVID-19 / Linfocitose Idioma: En Ano de publicação: 2021 Tipo de documento: Article